Progyny Inc reports results for the quarter ended March 31 - Earnings Summary
08/05/2025 23:35
Progyny Inc PGNY.OQ reported quarterly adjusted earnings of 17 cents per share for the quarter ended March 31, identical to the same quarter last year. The mean expectation of ten analysts for the quarter was for earnings of 19 cents per share. Wall Street expected results to range from 16 cents to 25 cents per share. Revenue rose 16.5% to $324.04 million from a year ago; analysts expected $307.86 million. Progyny Inc's reported EPS for the quarter was 17 cents. The company reported quarterly net income of $15.06 million. Progyny Inc shares had risen by 4.8% this quarter and gained 35.8% so far this year. FORECAST CHANGES The mean earnings estimate of analysts had risen by about 29% in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 6 "hold" and no "sell" or "strong sell." The average consensus recommendation for the managed healthcare peer group is also "buy" Wall Street's median 12-month price target for Progyny Inc is $28.00 This summary was machine generated from LSEG data May 8 at 10:35 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Mar. 31 2025 | 0.19 | 0.17 | Missed |
| Dec. 31 2024 | 0.10 | 0.12 | Beat |
| Sep. 30 2024 | 0.13 | 0.11 | Missed |
| Jun. 30 2024 | 0.17 | 0.17 | Met |